Business News

Cofepris accredited section three of the German CureVac vaccine in Mexico

Foreign Minister Marcelo Ebrard reported that phase 3 of the CureVac vaccine against coronavirus was approved by the Federal Commission for Protection against Health Risks (Cofepris).

Entrepreneur New Years Leader

Get inspiration from the business resources in our guide and help you meet your goals in 2021.

January
9, 2021

2 min read

This article has been translated from our Spanish edition using AI technologies. Errors can occur due to this process.

This story originally appeared on Alto Nivel

CureVac is a biopharmaceutical company of German origin. Cofepris has already approved phase 3 testing for these doses.

The Foreign Minister announced on his Twitter account that the Mexican government's federal agency has approved the final phase of testing, Phase 3, for the antidote to CureVac.

Image: @m_ebrard via Twitter

Similarly, on behalf of the Government of the Republic, the President thanked TecSalud for the support, especially Dr. Guillermo Torre to bring phase 3 of the vaccine developed by CUREVAC in Germany to Mexico.

Image: @m_ebrard via Twitter

What is known about the CureVac vaccine?

CureVac is a German biopharmaceutical company. According to the company that developed the vaccine: “Thanks to the technology we used to generate mRNA, we can give the body the information it needs to fight and cure diseases. Driven by our passion, we want to use our technology to help patients and extend people's lives. ""

That is, it is based on messenger mRNA, as is the case with Pfizer and BioNTech.

It's worth noting that Bayer and CureVac are working together on the development of the coronavirus vaccine. The two companies have reached an agreement to support the manufacture and commercialization of a messenger RNA vaccine to "facilitate supply".

Image: @CureVacRNA

In case you are interested: SRE: AstraZeneca Vaccine will arrive in Mexico on January 18th

Related Articles